Crossmark

Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling

Crossref DOI link: https://doi.org/10.1007/s40120-022-00350-y

Published Online: 2022-04-25

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tahami Monfared, Amir Abbas https://orcid.org/0000-0003-4003-3192
Tafazzoli, Ali

Ye, Weicheng

Chavan, Ameya

Zhang, Quanwu
License Information

Text and Data Mining valid from 2022-04-25

Version of Record valid from 2022-04-25
More Information

Article History

Received: 4 March 2022

Accepted: 28 March 2022

First Online: 25 April 2022